Skip to main content
Jeffrey Ross, MD, Pathology, Albany, NY, Albany Medical Center

JeffreySRossMD

Pathology Albany, NY

Anatomic Pathology, Clinical Pathology

Professor of Pathology, Albany Medical College

Are you Dr. Ross?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 49 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Jeffrey Ross, MD is a board certified pathologist in Albany, New York. He is currently licensed to practice medicine in New York, Vermont, and Massachusetts. He is affiliated with Albany Medical Center, Albany Stratton Veterans Affairs Medical Center, and Upstate University Hospital at Community Campus.

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 1970 - 1974
  • Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo
    Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1970

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1989 - 2024
  • MA State Medical License
    MA State Medical License 1972 - 2019
  • VT State Medical License
    VT State Medical License 1982 - 1984
  • American Board of Pathology Anatomic Pathology & Clinical Pathology

Publications & Presentations

PubMed

Press Mentions

  • Albany Med Urologists to Lead Men’s Health Conference
    Albany Med Urologists to Lead Men’s Health ConferenceAugust 7th, 2017
  • Albany Med Pathologist’s Pioneering Work Holds Promise for Cancer Patients
    Albany Med Pathologist’s Pioneering Work Holds Promise for Cancer PatientsFebruary 24th, 2015
  • Probing the Promising Future of Anti-HER2 Therapies for Micropapillary Bladder Cancer - Jeffrey Ross
    Probing the Promising Future of Anti-HER2 Therapies for Micropapillary Bladder Cancer - Jeffrey RossJune 29th, 2023

Hospital Affiliations